MM2 Prior to administering Gadolinium based MR contrast agent (GBMRCA), a patient's estimated Glomerular Filtration Rate (eGFR) should be obtained (within 6 weeks prior to Gadolinium administrations) when the patient meets one or more of the following criteria:

History of renal disease. Age = or > 60 years. History of hypertension. History of diabetes. Administration of Gadolinium contrast agent in excess of FDA approved dosing. History of severe hepatic disease or pending/recent liver transplant.

For patients in this last category, the patient's GFR assessment should be nearly contemporaneous with the MR examination for which GBMRCA is to be administered.

Refers to Standard:	MedicationManagementHAP
Applicable Programs:	HAP
Status:	Under development

Comments

Please Login or register to post comments.